News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Marcin Kortylewski: Multimodal Glioma Immunotherapy Targeting STAT3 and PD-1
Photo: Depositphotos
Apr 15, 2025, 09:48

Marcin Kortylewski: Multimodal Glioma Immunotherapy Targeting STAT3 and PD-1

Marcin Kortylewski, Professor at City of Hope, posted on LinkedIn:

“Just published! Our latest study on a new STAT3-targeting and double-stranded antisense oligonucleotide (CpG-STAT3dsASO) that reprograms the glioblastoma microenvironment and restores sensitivity to PD1 blockade. The oligo design was optimized for safety and led to long-term survival in preclinical GBM models.

Grateful to our expert collaborators including Amy Heimberger and Bozena Kaminska for their invaluable contributions to this work.”

“Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade.”

Authors: Chia-Yang Hung, Elaine Y Kang, Karol Jacek, Chunsong Yu, Xiaowei Zhang, Yicheng Zhu, Maryam Aftabizadeh, Robyn A Wong, Benham Badie, Piotr Swiderski, Bożena Kaminska, Darya Alizadeh, Amy B Heimberger, Christine Brown, Marcin Kortylewski

Marcin Kortylewski: Multimodal Glioma Immunotherapy Targeting STAT3 and PD-1

 

Amy B Heimberger Amy Heimberger Benham Badie Bozena Kaminska cancer Chia-Yang Hung Christine Brown Chunsong Yu Darya Alizadeh Elaine Y Kang glioblastoma immunotherapy Karol Jacek Marcin Kortylewski Maryam Aftabizadeh OncoDaily Oncology Piotr Swiderski Robyn A Wong Xiaowei Zhang Yicheng Zhu
Special Coverage
Blog
Apr 15, 2025, 09:48
Marcin Kortylewski: Multimodal Glioma Immunotherapy Targeting STAT3 and PD-1
Dialogues
Apr 15, 2025, 09:45
OnCoffee: Daniel Portik on Global Connections, Career in Oncology and more
Blog
Apr 15, 2025, 09:37
ALK Positive lung cancer community
Insight
Apr 15, 2025, 09:34
Servier’s Manette Le Grange on ACT4Children and Public-Private Collaboration
Blog
Apr 15, 2025, 09:30
Online guidance for sports after cancer treatment - Antoni van Leeuwenhoek
Blog
Apr 15, 2025, 09:24
Bhuvan Chugh presented case of CSF Sequencing in NSCLC done in collaboration with OneCell Diagnostics
Blog
Apr 15, 2025, 09:23
Gilles Vassal on Adding Temozolomide to the WHO Essential Medicines List
Blog
Apr 15, 2025, 09:17
Virgílio Souza: 5th International Symposium of the Brazilian Group on Gastrointestinal Tumors
Insight
Apr 15, 2025, 09:02
WHO’s Andre Ilbawi Highlights Global Cancer Medicine Access Challenges
Insight
Apr 15, 2025, 08:45
Guillermo Chantada Opens the Forum on Essential Medicines for Children with Cancer
Blog
Apr 15, 2025, 08:23
Stephen V Liu: Taletrectinib and zidesamtinib promise to move the field of ROS1 NSCLC by addressing resistance and safety
Positive
Apr 15, 2025, 08:03
Rawan Hammad: Thank you to the speakers, moderators, organizers and attendees who made SIOP Asia Riyadh 2025 a success!